Olaparib-induced interstitial lung disease: A case series analysis

Mototaka Hattori1, Yu Mikami1, Midori Sato1

  • 1Department of Respiratory Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

PubMed
Summary

Olaparib-induced interstitial lung disease (OILD) presents with fever and lung opacities on CT scans. High lymphocytosis in bronchoalveolar lavage fluid may help diagnose OILD, which responds to prednisolone treatment.